Identifying ST6GAL1 as a novel factor for human dermal fibroblast photoaging
Ontology highlight
ABSTRACT: Due to increasing global UV exposure from environmental changes and lifestyle factors, understanding the molecular mechanisms of photoaging is critical in dermatological research. This study addresses the underexplored role of glycosylation in dermal fibroblast photoaging by establishing an in vitro model using human dermal fibroblasts (HDF) exposed to UVA. Transcriptomic profiling revealed significant enrichment of gene sets associated with glycosylation and carbohydrate derivative synthesis. We employed lectin arrays and binding assays to identify candidate oligosaccharide ligands responsive to UVA exposure, revealing a marked upregulation of cell-surface sialylation levels during photoaging. Western blot analysis further indicated specific overexpression of the sialyltransferase ST6GAL1 in photoaged HDFs. Intervention with the sialyltransferase inhibitor 3FAx-Neu5Ac or ST6GAL1 gene silencing significantly alleviated the skin photoaging markers including p16, MMPs and SA-β-gal staining, while ST6GAL1 overexpression replicated these photoaging characteristics. Mechanistically, pathway analysis indicated that ST6GAL1 mediates photoaging via the regulation of the RAS-ERK-p16 signaling axis, while treatment with the RAS inhibitor reversed the phenotypic changes induced by ST6GAL1 knockdown. In a reconstructed human skin equivalent model of UVA photoaging, immunostaining confirmed the presence of ST6GAL1 alongside RAS and p16 induction. This study uniquely identifies ST6GAL1 as a specific biomarker for fibroblast photoaging, offering a novel therapeutic target for the diagnosis and intervention of photoaging.
ORGANISM(S): Homo sapiens
PROVIDER: GSE329475 | GEO | 2026/09/02
REPOSITORIES: GEO
ACCESS DATA